Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study

D. J. Lange, K. J. Felice, B. W. Festoff, M. J. Gawel, D. F. Gelinas, R. Kratz, E. C. Lai, M. F. Murphy, H. M. Natter, F. H. Norris, S. Rudnicki

Research output: Contribution to journalArticlepeer-review

50 Scopus citations
Original languageEnglish
Pages (from-to)S93-S95
JournalNeurology
Volume47
Issue number4 SUPPL.
DOIs
StatePublished - Oct 1996
Externally publishedYes

Cite this